Ceapro understands the importance of collaboration in our industry and is dedicated to developing long term, strategic partnerships. We are constantly seeking for in and out-licensing opportunities in the cosmeceuticals, nutraceuticals and pharmaceuticals sectors.

Our new chemical complex Co-enzyme Q10-Beta glucan is a licensing candidate for certain countries for cosmeceuticals, functional food and drink applications.

We are also offering specialized contract manufacturing services through the use of our unique proprietary process technologies.

For more information about business opportunities

Dr. Paul Moquin Ph.D.
Director, Scientific Affairs and New Business Development